Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

BBolt Biotherapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
B

Bolt Biotherapeutics, Inc.

$3.71Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $5K. Net result −$7.72M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $5K. Running result $5K. Revenue: $5K.
  • Cost of revenue: $0. Running result $5K.
  • Gross profit: $5K. Running result $5K.
  • Research and development: −$5.15M. Running result −$5.14M.
  • General and administrative: −$2.42M. Running result −$7.57M.
  • Impairment charges: −$808K. Running result −$8.37M.
  • Operating income: −$8.37M. Running result −$8.37M.
  • Other income: $654K. Running result −$7.72M.
  • Pre-tax loss: −$7.72M. Running result −$7.72M.
  • Income tax benefit: $0. Running result −$7.72M.
  • Net loss: −$7.72M. Running result −$7.72M.